Company / Gross Profit per Share
Amphstar Pharmaceuticals, Inc. Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$7.48
FY2025
5-year range
$4.21 / $7.78
FY2021-FY2025
Trend
-3.9%
vs FY2024
Sector context
#10 of 29
Health Care
What the data says
At $7.48, Amphstar Pharmaceuticals, Inc.'s gross profit per share ranks #10 of 29 in the Health Care sector. Improved from $7.30 to $7.48 over the past 2 years.
Based on SEC 10-K filings.
7.48 in FY2025 with a 5-year CAGR of +19.4%.
Improved from $7.30 to $7.48 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +12.8%
- 5-Year CAGR
- +19.4%
- 10-Year CAGR
- -
Sector benchmark
#10 of 29 in Health CareTop 34% of 29This company $7.48 Sector average $8.10
▼
-7.7% below sector average
Key checks
Key Insights
- In FY2025, gross profit per share decreased 3.9% year-over-year.
- Ranks #10 out of 29 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2024.
- Lowest gross profit per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.48 | -3.9% |
| FY2024 | $7.78 | +6.6% |
| FY2023 | $7.30 | +39.9% |
| FY2022 | $5.22 | +24.0% |
| FY2021 | $4.21 | +36.7% |
| FY2020 | $3.08 | +8.8% |
| FY2019 | $2.83 | +23.3% |
| FY2018 | $2.29 | +17.3% |
| FY2017 | $1.96 | -15.1% |
| FY2016 | $2.31 | +33.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026